Treatment of Metastatic Renal Cell Carcinoma With Nephrectomy, Interleukin-2 and Cytokine-Primed or CD8(+) Selected Tumor Infiltrating Lymphocytes from Primary Tumor
- 1 September 1997
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 158 (3) , 740-745
- https://doi.org/10.1016/s0022-5347(01)64304-0
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.Journal of Clinical Oncology, 1995
- Randomized comparison of high-dose and low-dose intravenous interleukin-2 for the therapy of metastatic renal cell carcinoma: an interim report.Journal of Clinical Oncology, 1994
- Interferons and interleukins in metastatic renal cell carcinomaUrology, 1993
- High-dose recombinant interleukin 2 in the treatment of patients with disseminated cancer. Responses, treatment-related morbidity, and histologic findingsJAMA, 1986
- Renal cell carcinoma: Survival and prognostic factorsUrology, 1986
- Validation of the Tumor, Nodes and Metastasis Classification of Renal Cell CarcinomaJournal of Urology, 1985
- Renal Cell Carcinoma: Long-Term Survival and Late RecurrenceJournal of Urology, 1981
- The Natural History of Metastatic Renal Cell Carcinoma: A Computer AnalysisJournal of Urology, 1978
- The Role of Adjunctive Nephrectomy in Patients with Metastatic Renal Cell CarcinomaJournal of Urology, 1977